To provide a diagnostic imaging of X-ray examination using computed tomography, capable of high sensitively detecting liver metastasis of a pancreatic cancer patient, which metastasis is hardly detectable by conventional methods, and to provide a medicine exhibiting remarkable effect on pancreatic cancer specifically unfavorable in prognosis in cancers.
The liver metastasis of a pancreatic cancer patient, which metastasis is conventionally hardly detectable, is high sensitively detectable by administering AT-II (angiotensin-II) of a vasoconstrictor with a contrast medium before X-ray examination. And, by using the AT-II with a conventional anticancer agent, remarkable suppressing effect on pancreatic cancer is exerted in comparison with single use of the anticancer agent.
COPYRIGHT: (C)2008,JPO&INPIT
| WO/2023/077375 | IN VIVO XRF AGENT |
| WO/2012/136813 | AGENTS FOR MEDICAL RADAR DIAGNOSIS |
| JPH05221958 | DIAMINOMERCAPTO(THIO)ETHER AS COMPLEXING AGENT FOR NUCLIDE WHICH CAN BE USED FOR NUCLEAR MEDICINE |
| JP2001048810A | 2001-02-20 | |||
| JPH0514042A | 1993-01-22 |
Keiko Morita